A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes

Name: A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
Creator: Vivli
Published: 2026-02-19 18:11:57
License: 暂无描述

DataCite Commons2026-02-19 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012777/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The main purpose of this study is to investigate the efficacy and safety of switching from weekly dulaglutide to weekly tirzepatide compared to increasing the dulaglutide dose in adults with type 2 diabetes.

提供机构：

Vivli

创建时间：

2026-02-19